Research Status of Biomarkers in Early Screening and Early Diagnosis of Lung Cancer
10.3971/j.issn.1000-8578.2022.21.0964
- VernacularTitle:生物标志物在肺癌早筛早诊应用中的研究现状
- Author:
Huihui LI
1
;
Xiaodan SUN
;
Peiyan ZHAO
;
Shuang ZHANG
;
Ying CHENG
Author Information
1. Clinical Medical College of Changchun University of Traditional Chinese Medicine, Changchun 130000, China
- Publication Type:Research Article
- Keywords:
Lung cancer;
Early screening and early diagnosis;
Liquid biopsy technique;
Biomarkers
- From:
Cancer Research on Prevention and Treatment
2022;49(4):364-369
- CountryChina
- Language:Chinese
-
Abstract:
Lung cancer is one of the most malignant tumors in the world. In China, the mortality rate of lung cancer has been in the first place for many years. Early screening and early diagnosis of lung cancer is the premise of prolonging the survival time of patients with lung cancer. In recent years, liquid biopsy technology, which is considered to have a bright future, has attracted more and more attention, and its value in the early diagnosis of lung cancer is worth discussing. This paper reviews the application of biomarkers in early screening and early diagnosis of lung cancer, looks for specific biomarkers from multi-omics, and discusses their significance in early diagnosis of lung cancer.
